Investment Date: September, 2020

Sector: Specialty Pharmaceuticals


Based in Dublin, Noden Pharma is a global specialty pharmaceutical company focused on acquiring prescription medicines across a range of therapeutic areas. Noden Pharma holds exclusive worldwide rights to manufacture, market and sell Tekturna and Tekturna HCT (or Rasilez and Rasilez HTC outside of the United States), which contain aliskiren, a direct renin inhibitor, for the treatment of hypertension for patients who are intolerant to the mainstream medicines on the market. To date, Noden Pharma sell its products in 13 countries globally.